Why global pharma is betting on India’s next-generation CDMOs
Hindustan Times · Jatin Gajjar ·
For years, India’s appeal as a contract development and manufacturing destination rested largely on cost competitiveness.
Read the full story at Hindustan Times · All coverage of this story